• Windham Hospital
• Hartford HealthCare Medical Group
• Backus Hospital
• Integrated Care Partners

Fellowship
New York Medical College

Internship
New York Medical College

Medical School
Government Medical College Patiala

Residency
New York Medical College

Verified Patient Reviews

January 27, 2023

White board diagrams illegible because he has a "doctor's handwriting." But he was talking so I knew what it said

January 17, 2023

I really liked the way he explained things using the white board, it made it much easier to follow and understand all the different things that could be going on. Then how we could treat them.

January 16, 2023

*Dr. Aujla is always very patient and takes the time to answer all of my questions & concerns.

Other Reviews from Around the Web

Reviewed on February 09, 2023

Always very thorough,polite and caring. I’m usually taken at or very close to my appointment time. Highly recommend.

Reviewed on February 01, 2023

Dr. Aujla is a caring Doctor and always listening when I talk to him.

Reviewed on January 17, 2023

Dr. Aujla is professional and communicative. I love that he uses a whiteboard to help explain complex processes.

Amandeep Aujla, MD, joined the Hartford Healthcare Cancer Institute in July 2020, and practices in the Norwich and Waterford offices. His practice is evolving and he sees patients with broad diagnoses of cancer with special interest in thoracic oncology, neuro-oncology and melanoma. After earning a medical degree in India, Dr. Aujla completed an internship, residency and fellowship in hematology and oncology at New York Medical College, where he also served as chief fellow in his third year. He has authored and participated in different projects focusing on breast cancer, kidney cancer, hematological malignancies, engraftment fever during stem cell transplantation and sickle cell disease. He also worked under the mentorship of Dr. Seah Lim, evaluating the role of targeting intestinal pathophysiology in decreasing vaso-occlusive crises in Sickle Cell Disease. The work led to the Food & Drug Administration designating Rifaxmin an orphan drug treatment for the disease.

Aetna, Anthem, BCBS Medicare, CarePartners of Connecticut, Cigna Healthcare, Colonial Cooperative Care, Community Health Network of Connecticut, Inc., Connecticare, Connecticare Commercial, Connecticare Medicare, Corvel, Coventry, Essence Healthcare, Evercare, First Health Group Corp., Focus, Harvard Pilgrim, Health Connecticut, Health Direct, Health New England, Healthy Connecticut, Multiplan, Northeast Health Direct, One Health Plan/ Great-West Healthcare, Oxford Health Plans, Prime Health Services, Private Health Care Systems, Inc., Senior Whole Health, United Healthcare, WellCare of Connecticut, Inc.

This information is subject to change at any time. Please check with your insurance provider before scheduling your appointment or receiving services to confirm they are a participating member of the Hartford HealthCare network.